Elevar Aims For Rivoceranib Turnaround After Positive Phase III Update

 
• By Jung Won Shin
  
Jumping
Rivoceranib To Become First Korea-Developed Cancer Drug Sold Globally? • Source: Shutterstock

More from Clinical Trials

More from R&D